Title:
カンナビノイドを含む放出調節組成物
Document Type and Number:
Japanese Patent JP7378402
Kind Code:
B2
Abstract:
The present invention relates to a novel cannabinoid oral pharmaceutical dosage form, based on a Type IV or Type IV-like formulation, as classified using the Lipid Formulation Classification System. The formulation comprises a combination of at least two cannabinoids. The first cannabinoid is selected from the group consisting of tetrahydrocannabinol (THC) and analogues thereof; and the second cannabinoid is selected from the group consisting of cannabidiol (CBD) and analogues thereof.
Inventors:
Zitinder Wilk
Johann Bender
Johann Bender
Application Number:
JP2020536983A
Publication Date:
November 13, 2023
Filing Date:
January 02, 2019
Export Citation:
Assignee:
G.W.Research Limited
International Classes:
A61K31/352; A61K9/48; A61K47/02; A61K47/10; A61K47/12; A61K47/14; A61K47/18; A61K47/20; A61K47/22; A61K47/24; A61P21/02; A61P25/04; A61P25/08; A61P25/18; A61P25/22; A61P25/28; A61P25/30; A61P29/02; A61P35/00; A61P43/00
Domestic Patent References:
| JP2017531667A | ||||
| JP2009514890A | ||||
| JP2019519556A | ||||
| JP2021509670A | ||||
| JP2021509667A |
Foreign References:
| CN103110582A | ||||
| WO2017059859A1 |
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mihiro
Tatsuhiko Abe
Shinya Mihiro
Tatsuhiko Abe